These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 17454172

  • 21. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
    Meczekalski B, Slopien R, Warenik-Szymankiewicz A.
    Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
    [Abstract] [Full Text] [Related]

  • 22. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC, Galluzzo A, Finocchiaro S, Criscimanna A, Giordano C.
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [Abstract] [Full Text] [Related]

  • 23. Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited.
    Kurzrock R, Cohen PR.
    Med Hypotheses; 2007 Jul; 68(3):480-3. PubMed ID: 17134841
    [Abstract] [Full Text] [Related]

  • 24. Association of genetic variants of insulin degrading enzyme with metabolic features in women with polycystic ovary syndrome.
    Wang K, You L, Shi Y, Wang L, Zhang M, Chen ZJ.
    Fertil Steril; 2008 Aug; 90(2):378-84. PubMed ID: 17953957
    [Abstract] [Full Text] [Related]

  • 25. Association between the polycystic ovary syndrome and the metabolic syndrome in Puerto Rico.
    Rabelo Acevedo M, Vick MR.
    P R Health Sci J; 2005 Sep; 24(3):203-6. PubMed ID: 16329683
    [Abstract] [Full Text] [Related]

  • 26. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
    Cussons AJ, Watts GF, Burke V, Shaw JE, Zimmet PZ, Stuckey BG.
    Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
    [Abstract] [Full Text] [Related]

  • 27. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population.
    Pehlivanov B, Orbetzova M.
    Gynecol Endocrinol; 2007 Oct; 23(10):604-9. PubMed ID: 17852429
    [Abstract] [Full Text] [Related]

  • 28. Specific haplotypes of the CALPAIN-5 gene are associated with polycystic ovary syndrome.
    González A, Sáez ME, Aragón MJ, Galán JJ, Vettori P, Molina L, Rubio C, Real LM, Ruiz A, Ramírez-Lorca R.
    Hum Reprod; 2006 Apr; 21(4):943-51. PubMed ID: 16396936
    [Abstract] [Full Text] [Related]

  • 29. Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up.
    Hudecova M, Holte J, Olovsson M, Larsson A, Berne C, Sundstrom-Poromaa I.
    Fertil Steril; 2011 Nov; 96(5):1271-4. PubMed ID: 21872228
    [Abstract] [Full Text] [Related]

  • 30. The metabolic syndrome in young Korean women with polycystic ovary syndrome.
    Park HR, Choi Y, Lee HJ, Oh JY, Hong YS, Sung YA.
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S243-6. PubMed ID: 17610984
    [Abstract] [Full Text] [Related]

  • 31. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
    Cheung LP, Ma RC, Lam PM, Lok IH, Haines CJ, So WY, Tong PC, Cockram CS, Chow CC, Goggins WB.
    Hum Reprod; 2008 Jun; 23(6):1431-8. PubMed ID: 18359783
    [Abstract] [Full Text] [Related]

  • 32. Calpain-10 genetic polymorphisms and polycystic ovary syndrome risk: a meta-analysis and meta-regression.
    Shen W, Li T, Hu Y, Liu H, Song M.
    Gene; 2013 Dec 01; 531(2):426-34. PubMed ID: 23994294
    [Abstract] [Full Text] [Related]

  • 33. Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome.
    Van Nieuwerburgh F, Stoop D, Cabri P, Dhont M, Deforce D, De Sutter P.
    Gynecol Endocrinol; 2008 Dec 01; 24(12):669-73. PubMed ID: 19172534
    [Abstract] [Full Text] [Related]

  • 34. Common polymorphisms of calpain-10 and the risk of polycystic ovary syndrome in Tunisian population: a case-control study.
    Ben Salem A, Attaoua R, Mtiraoui N, Belkahla S, Ezzidi I, Ajina M, Souissi M, Poucheret P, Vintila M, Grigorescu F, Mahjoub T.
    Mol Biol Rep; 2014 Oct 01; 41(10):6569-74. PubMed ID: 24993116
    [Abstract] [Full Text] [Related]

  • 35. Metabolic syndrome in polycystic ovary syndrome.
    Carmina E.
    Minerva Ginecol; 2006 Apr 01; 58(2):109-14. PubMed ID: 16582867
    [Abstract] [Full Text] [Related]

  • 36. Development of polycystic ovary syndrome: involvement of genetic and environmental factors.
    Franks S, McCarthy MI, Hardy K.
    Int J Androl; 2006 Feb 01; 29(1):278-85; discussion 286-90. PubMed ID: 16390494
    [Abstract] [Full Text] [Related]

  • 37. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN, Merchant R.
    Semin Reprod Med; 2008 Jan 01; 26(1):22-34. PubMed ID: 18181079
    [Abstract] [Full Text] [Related]

  • 38. Association of the 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) with hyperandrogenemia in polycystic ovary syndrome (PCOS).
    Marioli DJ, Saltamavros AD, Vervita V, Koika V, Adonakis G, Decavalas G, Markou KB, Georgopoulos NA.
    Fertil Steril; 2009 Aug 01; 92(2):648-52. PubMed ID: 18692800
    [Abstract] [Full Text] [Related]

  • 39. The (TAAAA)n microsatellite polymorphism in the SHBG gene influences serum SHBG levels in women with polycystic ovary syndrome.
    Ferk P, Teran N, Gersak K.
    Hum Reprod; 2007 Apr 01; 22(4):1031-6. PubMed ID: 17189294
    [Abstract] [Full Text] [Related]

  • 40. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria.
    Kauffman RP, Baker TE, Baker VM, DiMarino P, Castracane VD.
    Am J Obstet Gynecol; 2008 Jun 01; 198(6):670.e1-7; discussion 670.e7-10. PubMed ID: 18355776
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.